Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Fever × Clear all

Phase

Status

Completed 31 Unknown 5 Withdrawn 3 Terminated 3 Recruiting 3 Not yet recruiting 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 724 Carcinoma, Non-Small-Cell Lung 464 Neoplasms 434 Prostatic Neoplasms 411 Colorectal Neoplasms 265 Multiple Myeloma 256 Lung Neoplasms 250 Neoplasm Metastasis 216 Melanoma 211 Pancreatic Neoplasms 190 Ovarian Neoplasms 188 Leukemia, Myeloid, Acute 181 Squamous Cell Carcinoma of Head and Neck 150 Recurrence 147 Carcinoma, Renal Cell 138 Brain Neoplasms 138 Lymphoma 137 Glioblastoma 137 Stomach Neoplasms 136 Carcinoma, Hepatocellular 131 Lymphoma, Non-Hodgkin 126 Head and Neck Neoplasms 122 Precursor Cell Lymphoblastic Leukemia-Lymphoma 118 Leukemia, Lymphocytic, Chronic, B-Cell 117 Triple Negative Breast Neoplasms 114 Uterine Cervical Neoplasms 107 Colonic Neoplasms 107 Urinary Bladder Neoplasms 105 Lymphoma, Large B-Cell, Diffuse 104 Hematologic Neoplasms 102

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01972347 2025-12-16

Neo Combi

Melanoma Institute Australia

Phase 2 Active not recruiting

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡